Payer’s Place: Dr. Matthew Hurford, UPMC Health Plan
How UPMC Health Plan is taking steps in providing better behavioral health support.
Payer’s Place: Shantanu Agrawal, MD, MPHIL, Elevance Health
Elevance Health is finding ways to connect with the community in order to achieve better health equity.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Payer’s Place: Camille Harrison, GuideWell, Florida Blue
What does the future hold with AI and the healthcare ecosystem? Camille Harrison with GuideWell, Florida Blue joins the Payer's Place to share her thoughts.
Payer’s Place: Dawn Maroney, Alignment Health
CEO of Alignment Health joins the Payer's Place and details how the growth of Medicare Advantage will only help patients in the future.
Payer’s Place: Dr. Anil Singh, Highmark Health
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
The Expanding Role of Benefit Consultants as Employers Look to Navigate Change
This new report sheds light on how the benefit consultants’ role has changed and details their perspective on the shifting employer healthcare landscape.
Payer’s Place: Don Antonucci, Providence Health Plan
The CEO of Providence Health Plan visits the Payer's Place and addresses the future of payment models.
Payer’s Place: Carrie Kincaid, Priority Health
Carrie Kincaid, Senior Vice President, Market Development at Priority Health discusses how Priority Health is addressing the gaps in rural healthcare.
Payer’s Place: Peter Long, Blue Shield of California
Peter Long of Blue Shield of California discusses how they focus on member experience and ways to improve their overall healthcare needs.
Payer’s Place: David Calabrese
OptumRx's Chief Clinical Officer shares his insights on the latest developments and trends he's seen in the healthcare industry.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
A Look at the Cybersecurity War in Healthcare and How Healthcare Organizations Are Responding
Learn how to identify bad actors from instigating cyber attacks and what stakeholders are doing at the regional and national levels to address this crisis.
How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact
The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.
What Does It Really Mean To Deliver ‘Whole-person Care’?
At Thyme Care, see what whole-person care means to us.
How to navigate the challenges of working with low-code platforms
Learn how planning for the strategic use of a low-code platform helps provide long-term benefits and helps to avoid issues resulting from suboptimal use of the products.
The art of clinical trials: Getting eConsent right
As life science companies seek to boost clinical trial participation, eConsent forms can pose a stumbling block. A white paper by Medable shares some insights on how companies can leverage eConsent to improve clinical trial recruitment and retention.